NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 49 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $667,455 | -67.0% | 623,790 | -20.2% | 0.00% | -100.0% |
| Q2 2023 | $2,023,663 | +64409.5% | 781,337 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $3,137 | -17.5% | 768,884 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $3,803 | -100.0% | 757,753 | +2.6% | 0.00% | -75.0% |
| Q3 2022 | $9,664,000 | +40.8% | 738,810 | +38.0% | 0.00% | +33.3% |
| Q2 2022 | $6,864,000 | +82.9% | 535,438 | +116.8% | 0.00% | +200.0% |
| Q1 2022 | $3,752,000 | -17.2% | 247,026 | -3.4% | 0.00% | 0.0% |
| Q4 2021 | $4,529,000 | +11.8% | 255,760 | +45.4% | 0.00% | 0.0% |
| Q3 2021 | $4,052,000 | +65.5% | 175,936 | +41.7% | 0.00% | 0.0% |
| Q2 2021 | $2,449,000 | -51.2% | 124,163 | -28.1% | 0.00% | -50.0% |
| Q1 2021 | $5,020,000 | +65.8% | 172,676 | +72.7% | 0.00% | +100.0% |
| Q4 2020 | $3,028,000 | +102.8% | 99,980 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $1,493,000 | -32.5% | 93,837 | -16.3% | 0.00% | 0.0% |
| Q2 2020 | $2,213,000 | +56.8% | 112,118 | -2.0% | 0.00% | 0.0% |
| Q1 2020 | $1,411,000 | -65.7% | 114,438 | -48.6% | 0.00% | -50.0% |
| Q4 2019 | $4,113,000 | +1146.4% | 222,469 | +833.4% | 0.00% | – |
| Q3 2019 | $330,000 | +124.5% | 23,834 | +138.0% | 0.00% | – |
| Q2 2019 | $147,000 | – | 10,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 16,245,817 | $247,749,000 | 45.93% |
| Ponoi II Management, LLC | 1,298,908 | $19,808,000 | 43.96% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $57,442,000 | 39.74% |
| Ponoi Management, LLC | 1,298,908 | $19,808,000 | 25.71% |
| Euclidean Capital LLC | 746,674 | $11,387,000 | 6.62% |
| StepStone Group LP | 1,573,357 | $23,994,000 | 1.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,494 | $3,058,000 | 1.26% |
| First Light Asset Management, LLC | 816,653 | $12,454,000 | 1.10% |
| BVF INC/IL | 955,000 | $14,564,000 | 0.58% |
| HighVista Strategies LLC | 46,243 | $705,000 | 0.45% |